What is Bevacizumab-awwb: Uses, Dosage, Side Effects and More

Bevacizumab-awwb is a biosimilar cancer medication that helps treat certain types of cancer by blocking blood vessel growth to tumors. It's a laboratory-made antibody that mimics your body's natural immune proteins, designed to starve cancer cells of the nutrients they need to grow and spread.

This medication belongs to a class of drugs called angiogenesis inhibitors, which means it stops tumors from creating new blood vessels. Think of it as cutting off the supply lines that feed cancer cells, making it harder for them to survive and multiply in your body.

What is Bevacizumab-awwb?

Bevacizumab-awwb is a biosimilar version of the original bevacizumab medication. A biosimilar is essentially a highly similar copy of an already approved biological medicine that works in the same way as the original drug.

The medication is a monoclonal antibody, which means it's designed to target one specific protein in your body. In this case, it targets a protein called VEGF (vascular endothelial growth factor) that cancer cells use to build new blood vessels.

You'll receive this medication through an intravenous (IV) infusion, which means it goes directly into your bloodstream through a vein. The "awwb" part of the name simply helps distinguish this particular biosimilar from other versions.

What is Bevacizumab-awwb Used For?

Bevacizumab-awwb treats several types of advanced or metastatic cancers. Your doctor will typically prescribe it when cancer has spread to other parts of your body or when other treatments haven't been effective enough.

The medication is commonly used for colorectal cancer, particularly when it has spread to other organs. It's often combined with chemotherapy drugs to make the overall treatment more effective at fighting the cancer.

Other cancers that may be treated with this medication include certain types of lung cancer, kidney cancer, and cervical cancer. Your oncologist will determine if this treatment is right for your specific type and stage of cancer.

Sometimes doctors use bevacizumab-awwb for recurrent glioblastoma, a type of aggressive brain tumor. In these cases, it may help slow tumor growth when other treatments have stopped working.

How Does Bevacizumab-awwb Work?

Bevacizumab-awwb works by blocking a protein called VEGF that cancer cells use to grow new blood vessels. When cancer cells can't create these new blood vessels, they struggle to get the oxygen and nutrients they need to survive and multiply.

This is considered a targeted therapy rather than traditional chemotherapy. Instead of attacking all rapidly dividing cells, it specifically targets the mechanism that helps tumors grow their blood supply.

The medication doesn't kill cancer cells directly like some other treatments do. Instead, it weakens them by cutting off their lifeline, making them more vulnerable to other cancer treatments you might be receiving.

This approach can help slow tumor growth and may make chemotherapy more effective when used together. However, it's considered a supportive treatment rather than a cure on its own.

How Should I Take Bevacizumab-awwb?

You'll receive bevacizumab-awwb as an intravenous infusion at a hospital or cancer treatment center. The medication must be given by trained healthcare professionals who can monitor you during the treatment.

Your first infusion will typically take about 90 minutes, allowing your medical team to watch carefully for any reactions. If you tolerate the first dose well, future infusions may be given over 60 minutes, and eventually over 30 minutes.

The medication is usually given every 2-3 weeks, depending on your specific treatment plan and the other medications you're receiving. Your oncologist will determine the exact schedule based on your cancer type and overall health.

You don't need to fast or follow any special diet before your infusion. However, it's important to stay well-hydrated and eat normally unless your doctor gives you different instructions.

How Long Should I Take Bevacizumab-awwb For?

The duration of treatment with bevacizumab-awwb varies significantly depending on your cancer type, how well you respond to treatment, and how well you tolerate the medication. Some people receive it for several months, while others may need it for over a year.

Your oncologist will regularly monitor your cancer through scans and blood tests to see how well the treatment is working. If your cancer is responding well and you're not experiencing severe side effects, treatment may continue.

Treatment typically stops if your cancer progresses despite the medication, if you develop serious side effects, or if your doctor determines that the risks outweigh the benefits. Sometimes treatment may be paused temporarily if you need surgery or develop certain complications.

The decision to continue or stop treatment is always made collaboratively between you and your oncology team, taking into account your overall health, quality of life, and treatment goals.

What are the Side Effects of Bevacizumab-awwb?

Bevacizumab-awwb can cause various side effects, ranging from mild to serious. Most people experience some side effects, but many are manageable with proper medical care and monitoring.

Here are the more common side effects you might experience during treatment:

• High blood pressure, which your doctor will monitor closely
• Fatigue and weakness that may affect your daily activities
• Decreased appetite and weight loss
• Diarrhea or changes in bowel movements
• Nausea and occasional vomiting
• Nosebleeds or bleeding gums
• Headaches that may come and go
• Changes in taste or mouth sores

These common side effects are generally manageable, and your healthcare team can provide medications or strategies to help you feel more comfortable.

There are also some serious but less common side effects that require immediate medical attention. While these don't happen to everyone, it's important to be aware of them:

• Severe bleeding, including internal bleeding
• Blood clots in legs, lungs, or other organs
• Kidney problems or changes in urination
• Severe high blood pressure that doesn't respond to medication
• Bowel perforation (a hole in the intestine)
• Slow wound healing or wound complications
• Heart problems or congestive heart failure
• Stroke or other neurological problems

Your medical team will monitor you closely for these serious side effects and will teach you what warning signs to watch for at home.

Some rare but serious side effects include reversible posterior leukoencephalopathy syndrome (RPLS), which affects the brain, and severe allergic reactions during infusion. These are uncommon but require immediate medical attention if they occur.

Who Should Not Take Bevacizumab-awwb?

Bevacizumab-awwb isn't suitable for everyone, and your doctor will carefully evaluate whether it's safe for you. Certain medical conditions or situations make this medication too risky to use.

You shouldn't receive this medication if you're pregnant or breastfeeding, as it can harm your developing baby. Women of childbearing age need to use effective birth control during treatment and for several months after the last dose.

People with recent or upcoming surgery may not be candidates for this treatment. The medication can interfere with wound healing, so your doctor will typically wait until you've fully healed from surgery before starting treatment.

Here are other conditions that may prevent you from receiving bevacizumab-awwb:

• Uncontrolled high blood pressure
• Recent heart attack or stroke
• Active bleeding or bleeding disorders
• Severe liver or kidney disease
• History of bowel perforation
• Certain types of brain tumors with high bleeding risk
• Allergic reactions to bevacizumab or similar medications

Your oncologist will review your complete medical history and current health status to determine if this treatment is appropriate for you.

Bevacizumab-awwb Brand Names

Bevacizumab-awwb is available under the brand name Mvasi. This biosimilar was developed to provide a more affordable option compared to the original bevacizumab medication.

The original bevacizumab is sold under the brand name Avastin. Both medications work in essentially the same way and have similar effectiveness and safety profiles.

Your insurance or treatment center may determine which version you receive. Both are considered equally effective for treating cancer, so you can feel confident in either option your doctor prescribes.

Bevacizumab-awwb Alternatives

Several alternative treatments exist for the cancers that bevacizumab-awwb treats. Your oncologist will consider these options based on your specific cancer type, stage, and overall health.

Other angiogenesis inhibitors include ramucirumab and aflibercept, which work similarly by blocking blood vessel growth to tumors. These medications may be options if bevacizumab-awwb isn't suitable for you or stops working.

Targeted therapies like cetuximab or panitumumab may be alternatives for certain types of colorectal cancer, especially if your tumor has specific genetic characteristics. These work differently by targeting proteins on cancer cell surfaces.

Traditional chemotherapy regimens remain important treatment options and are often used in combination with or instead of bevacizumab-awwb. Your oncologist will help determine the best treatment approach for your situation.

Is Bevacizumab-awwb Better Than Avastin?

Bevacizumab-awwb (Mvasi) and Avastin are essentially equivalent medications with the same effectiveness and safety profile. The main difference is that bevacizumab-awwb is a biosimilar, which typically costs less than the original medication.

Clinical studies have shown that biosimilar medications like bevacizumab-awwb work just as well as their original counterparts. The FDA requires biosimilars to meet strict standards proving they're highly similar to the original drug.

Your doctor may choose one over the other based on factors like cost, insurance coverage, or availability at your treatment center. Both medications will give you the same cancer-fighting benefits.

The choice between them often comes down to practical considerations rather than medical ones, since both are considered equally effective and safe for treating cancer.